SC: Disciplinary Proceedings Cannot Follow if an Officer is Discharged on the Same Charge || SC Clarified the Distinction Between Arbitration “Seat” And “Venue” While Summarising Key Principles || Supreme Court: Wife and Her Family Cannot Be Prosecuted For Dowry-Giving Based On Her Complaint || SC: Plaint Cannot Be Rejected Under Order VII Rule 11 CPC on the Ground of Order II Rule 2 Bar || Supreme Court Has Issued an SOP Prescribing Strict Timelines For Filing Legal Aid Appeals || Madras HC: Dhurandhar 2 Release Cannot be Stalled Due to Objections From a Small Section || Delhi HC: Lokpal May Form Prima Facie Opinion Before Show Cause Notice Without Prior Hearing || Bom HC: Family Courts Cannot Casually Order a Spouse’s Medical Examination to Assess Mental Health || Bombay HC: Child Care Leave Protects Motherhood and Denial Violates Rights of Mother and Child || Supreme Court: Amalgamating Company Loss Cannot be Set Off Against Amalgamated Income

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :